Suscribe to our Newsletter

lunes, 7 de enero de 2013

Call for Papers: Translational Biomedicine


Call for Papers: 

Translational Biomedicine Journal

Index Copernicus Value 2011: 5.09


Dear Colleague,
Let me introduce you Translational Biomedicine (TBM).
TBM is an international, peer-reviewed, hybrid journal which publishes high quality articles from all areas and fields which have an impact to understand human biology, pathogenesis, diagnosis and treatment for human diseases. Translational Biomedicine related event’s proceedings and abstracts are also published.

TBM is published by iMedPub. Our journal is indexed in reputed search engines. We have world famous expert scientists on our editorial board. More information about the Journal is available on our website.

Invitation to become Reviewer
We invite you to become reviewer for TBM. 
You can register here.

We also invite you to submit your valuable work for publication in TBM. TBM welcomes Original Research Manuscripts, Methodology, Protocol, Clinical trials, Case Reports, Comprehensive and Mini Review Articles and Short Communications from all areas and fields. These may be either from you or from your colleagues/faculty. Please follow Instructions to the author for preparing your manuscript TBM. 
Average First decision in 7 days
Negative studies are equally welcome

Please forward this journal call for papers to your colleagues. Thanks in advance.

We look forward to your positive response. If you have any questions, please feel free to ask.

Best Regards,
The Headhunter

Are you interested in medical publishing? Are you a skilled scientific writer? Perhaps wishing to become a dedicated editor of books or journals? social network can help you maintain existing personal and professional relationships and establish new ones by reaching out to Doctors you've never met before.

Medbrary is a digital medical library to assist health care professionals and biomedical researchers in finding health and scientific information. 

Copyright © 2012 iMedPub, All rights reserved. 

No hay comentarios:

Publicar un comentario